.Regeneron is actually back with long-term consequence for its LAG-3 prevention and PD-1 inhibitor c...
.AstraZeneca has discussed a very early consider the functionality of its internal antibody-drug con...
.After introducing a stage 3 launch based on good midstage results, iTeos and GSK are actually lastl...
.The FDA needs to be actually more available as well as joint to release a rise in approvals of rare...
.It is actually an extraordinarily active Friday for biotech IPOs, with Zenas BioPharma, MBX and Bic...
.Atea Pharmaceuticals' antiviral has fallen short another COVID-19 trial, however the biotech still ...
.Neurocrine Biosciences' mental illness program pivot has actually neglected. The biotech was unable...
.Sanofi has created a late entry to the radioligand gathering, spending one hundred thousand euros (...
.After F2G's first attempt to obtain a new training class of antifungal to market was actually derai...
.Moderna has actually vowed to cut R&D costs by $1.1 billion by 2027. The choice to retract the b...